All In Biotech

Drug Trial Radar · NCT07226258

Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain

A Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety and Efficacy of SL1002 Injectable for the Treatment of Knee Pain in Patients With Osteoarthritis of the Knee

Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 150 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

150

Planned (sponsor's estimate)

Start

Nov 7, 2025

Primary completion

Nov 30, 2026

Study completion Feb 28, 2027

Sponsor

Lead sponsor
Saol Therapeutics IncIndustry
Sponsor type
Industry
First posted
Nov 10, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Sequential
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety and Efficacy of SL1002 for the Treatment of Knee Pain in Patients with Osteoarthritis of the Knee.

Conditions

  • Osteoarthritis Knee Pain

Interventions

  • SL1002Drug

    SL1002 injectable solution

  • Normal SalineDrug

    Normal Saline

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline to Week 12 in the Weekly Mean of the Average Daily Pain Intensity While WalkingTime frame: Baseline to week 12

Locations

22 sites in 1 country. Site status is shown where the registry gives one.

  • Sutter Neurology and Pain Management

    Roseville, California

  • Innovative Pain Treatment Solutions

    San Diego, California

  • DBPS Research, LLC

    Greenwood Village, Colorado

  • International Spine, Pain & Performance Center

    Washington D.C., District of Columbia

  • Prime Medical Research

    Coral Gables, Florida

  • Conquest Research, LLC

    Orlando, Florida

  • Interventional Pain Institute

    The Villages, Florida

  • Conquest Research, LLC

    Winter Park, Florida

  • Mayo Clinic

    Rochester, Minnesota

  • Queen City Clinical Research, PLLC

    Charlotte, North Carolina

  • The Center for Clinical Research

    Winston-Salem, North Carolina

  • Comprehensive Specialty Care

    Edmond, Oklahoma

  • Pacific Sports and Spine

    Eugene, Oregon

  • University Orthopedics Center

    Altoona, Pennsylvania

  • Pain Diagnostics & Interventional Care LLC

    Sewickley, Pennsylvania

  • Medical University of South Carolina (MUSC)

    Charleston, South Carolina

  • PCPMG Clinical Research Unit, LLC

    Greenville, South Carolina

  • Legent Orthopedic and Spine Hospital

    Bellaire, Texas

  • Institute of Precision Pain Medicine

    Corpus Christi, Texas

  • International Spine, Pain & Performance Center (IPP)

    Tyler, Texas

  • University of Utah Orthopedic Center

    Salt Lake City, Utah

  • Virginia iSpine Physicians, PC

    Richmond, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.